Heron Therapeutics, Inc. (HRTX)
$0.36-7.69%Close
BUYCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $57M
- Beta
- 1.63
- P/E (TTM)
- -1.93
- Short % float
- 34.83%
- Days to cover
- 17.3
- SI change
- +6.1%
- 1W
- -5.26%
- 1M
- +16.13%
- vs SPY 1W
- -5.12%
- vs SPY 1M
- +13.62%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on HRTX?
- LOPJLB’s latest quantitative signal on Heron Therapeutics, Inc. (HRTX) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is HRTX in?
- Heron Therapeutics, Inc. (HRTX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Heron Therapeutics, Inc. (HRTX) do?
- Heron Therapeutics, Inc. is a biotechnology firm dedicated to creating innovative therapies for critical patient requirements. The company leverages its proprietary Biochronomer drug delivery platform, an advanced system that enables the controlled release of various short-acting pharmacological agents. This technology ensures therapeutic concentrations are maintained for periods ranging from d…